pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Amvuttra · news · pharmadog
← back to Amvuttra
News mentioning Amvuttra
17
stories
19d
5 biotechs braving the commercial waters with product launches
biospace
Aug 31, 26
ESC ‘26: Cytokinetics’ sell-off, Arrowhead’s edge and a heart drug autopsy
biopharma dive
Aug 31, 26
ESC: Alnylam's next-gen silencer sees silver linings after fallout of AZ, Ionis trial in ATTR-CM
fiercebiotech
Aug 30, 26
STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua
stat
Aug 28, 26
‘Worse than expected’ Wainua data muddies water for TTR silencers
biospace
Aug 28, 26
AstraZeneca, Ionis data spark debate about RNA drugs’ impact on deadly heart disease
biopharma dive
Aug 27, 26
What’s in Merck and Moderna’s cancer vaccine algorithm?
stat
Aug 12, 26
BridgeBio continues ATTR ascent as Alnylam’s Amvuttra falls short of expectations
biospace
Aug 3, 26
5 companies advancing ATTR assets in the wake of Wainua’s fail
biospace
Jul 31, 26
Alnylam absorbs $10.8B blowback after cutting full-year guidance for TTR franchise
biospace
Jul 30, 26
Alnylam plunges as earnings deliver ‘one-two punch’
biopharma dive
Jul 30, 26
Alnylam cuts Amvuttra sales guidance as demand shifts, hurting stock
endpoints
Jul 29, 26
Biotechs bring big launches and pharma rivalries into Q2 earnings period
biospace
Jul 22, 26
Royalty Pharma pens $425M deal for slice of sales on AstraZeneca’s ATTR drug
fiercebiotech
Jul 9, 26
AstraZeneca, Ionis drug fails big heart disease study in major setback
biopharma dive
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Apr 28, 26
Pfizer deals extend patent life for a top-selling rare disease drug
biopharma dive
